Case Control Study
Copyright ©The Author(s) 2022.
World J Clin Cases. May 16, 2022; 10(14): 4380-4394
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4380
Table 3 Comparison of 1-year, 3-year and 5-year cumulative survival rates between the high and the low neutrophil-lymphocyte ratio group
Cutoff value of NLR1-yr CSRa3-yr CSRa5-yr CSRaChi-squareP value
NLR ≥ 441.7% vs 82.5%10.4% vs 60.9%0.0% vs 41.7%15.9690.000a
NLR ≥ 3 (n = 26)52.0% vs 87.3%19.1% vs 67.2%0.0% vs 48.3%22.1920.000a
NLR ≥ 265.8% vs 88.9%46.5% vs 61.1%31.0% vs 34.0%2.0150.156
NLR ≥ 175.3% vs 85.7%52.6% vs -30.6% vs -0.4590.498